[go: up one dir, main page]

SG11201507510PA - Isolation of non-embryonic stem cells and uses thereof - Google Patents

Isolation of non-embryonic stem cells and uses thereof

Info

Publication number
SG11201507510PA
SG11201507510PA SG11201507510PA SG11201507510PA SG11201507510PA SG 11201507510P A SG11201507510P A SG 11201507510PA SG 11201507510P A SG11201507510P A SG 11201507510PA SG 11201507510P A SG11201507510P A SG 11201507510PA SG 11201507510P A SG11201507510P A SG 11201507510PA
Authority
SG
Singapore
Prior art keywords
isolation
stem cells
embryonic stem
embryonic
cells
Prior art date
Application number
SG11201507510PA
Inventor
Wa Xian
Original Assignee
Jackson Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson Lab filed Critical Jackson Lab
Publication of SG11201507510PA publication Critical patent/SG11201507510PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0679—Cells of the gastro-intestinal tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0685—Bladder epithelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0695—Stem cells; Progenitor cells; Precursor cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/42—Notch; Delta; Jagged; Serrate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/52—Fibronectin; Laminin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201507510PA 2013-03-15 2014-03-14 Isolation of non-embryonic stem cells and uses thereof SG11201507510PA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361792027P 2013-03-15 2013-03-15
US201361912795P 2013-12-06 2013-12-06
PCT/US2014/027207 WO2014152321A1 (en) 2013-03-15 2014-03-14 Isolation of non-embryonic stem cells and uses thereof

Publications (1)

Publication Number Publication Date
SG11201507510PA true SG11201507510PA (en) 2015-10-29

Family

ID=50639961

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201507510PA SG11201507510PA (en) 2013-03-15 2014-03-14 Isolation of non-embryonic stem cells and uses thereof
SG10201708332WA SG10201708332WA (en) 2013-03-15 2014-03-14 Isolation of non-embryonic stem cells and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201708332WA SG10201708332WA (en) 2013-03-15 2014-03-14 Isolation of non-embryonic stem cells and uses thereof

Country Status (8)

Country Link
US (2) US20160060594A1 (en)
EP (1) EP2970892A1 (en)
JP (2) JP6602745B2 (en)
AU (1) AU2014239954B2 (en)
CA (1) CA2906643A1 (en)
SG (2) SG11201507510PA (en)
TW (1) TW201522637A (en)
WO (1) WO2014152321A1 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
US9096832B2 (en) 2007-07-31 2015-08-04 Lifescan, Inc. Differentiation of human embryonic stem cells
CN107574142B (en) 2007-11-27 2021-07-06 生命扫描有限公司 Differentiation of human embryonic stem cells
CA2959401C (en) 2008-02-21 2021-12-07 Centocor Ortho Biotech Inc. Methods, surface modified plates and compositions for cell attachment, cultivation and detachment
KR20180018839A (en) 2008-06-30 2018-02-21 얀센 바이오테크 인코포레이티드 Differentiation of pluripotent stem cells
US9234178B2 (en) 2008-10-31 2016-01-12 Janssen Biotech, Inc. Differentiation of human pluripotent stem cells
ES2584053T3 (en) 2008-11-20 2016-09-23 Janssen Biotech, Inc. Methods and compositions for cell binding and culture in flat substrates
MX356756B (en) 2008-11-20 2018-06-11 Centocor Ortho Biotech Inc Pluripotent stem cell culture on micro-carriers.
WO2011011300A2 (en) 2009-07-20 2011-01-27 Centocor Ortho Biotech Inc. Differentiation of human embryonic stem cells
KR101773538B1 (en) 2009-12-23 2017-08-31 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells
PH12012501686A1 (en) 2010-03-01 2020-10-19 Janssen Biotech Inc Methods for purifying cells derived from pluripotent stem cells
CN102884176B (en) 2010-05-12 2017-09-05 詹森生物科技公司 Differentiation of human embryonic stem cells
RU2620938C2 (en) 2010-08-31 2017-05-30 Янссен Байотек, Инк. Differentiation of human embryonic stem cells
US9388386B2 (en) 2011-12-22 2016-07-12 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into single hormonal insulin positive cells
US9434920B2 (en) 2012-03-07 2016-09-06 Janssen Biotech, Inc. Defined media for expansion and maintenance of pluripotent stem cells
CN108103005A (en) 2012-06-08 2018-06-01 詹森生物科技公司 Differentiation of the human embryo stem cell to pancreatic endocrine cell
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
SG10201709338RA (en) 2012-12-31 2017-12-28 Janssen Biotech Inc Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
JP6529440B2 (en) 2012-12-31 2019-06-12 ヤンセン バイオテツク，インコーポレーテツド Suspension and clustering of human pluripotent cells for differentiation to pancreatic endocrine cells
SG11201507510PA (en) * 2013-03-15 2015-10-29 Jackson Lab Isolation of non-embryonic stem cells and uses thereof
US20160237400A1 (en) * 2013-03-15 2016-08-18 The Jackson Laboratory Isolation of non-embryonic stem cells and uses thereof
CN117821369A (en) 2014-05-16 2024-04-05 詹森生物科技公司 Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
CA2981708C (en) 2015-04-03 2024-09-10 Propagenix Inc. Ex vivo proliferation of epithelial cells
US10100285B2 (en) 2015-04-03 2018-10-16 Propagenix Inc. Ex vivo proliferation of epithelial cells
US10087417B2 (en) 2015-04-22 2018-10-02 William J. Freed Three-dimensional model of human cortex
EP3307874A4 (en) * 2015-06-12 2019-04-24 Agency For Science, Technology And Research DERIVATION OF HEPATIC STEM CELLS AND TYPES OF HEPATIC CELLS AND ASSOCIATED USES THEREOF
DK3347450T3 (en) 2015-09-11 2021-05-31 Propagenix Inc EX VIVO PROLIFERATION OF EPITHEL CELLS
CN108884445A (en) * 2016-03-09 2018-11-23 北京智康博药肿瘤医学研究有限公司 Tumour cell suspension culture and correlation technique
CN107267437B (en) * 2016-04-08 2021-01-19 苏州吉美瑞生医学科技有限公司 Kit and method for isolating and obtaining lung stem cells
MA45479A (en) 2016-04-14 2019-02-20 Janssen Biotech Inc DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN ENDODERMAL CELLS OF MIDDLE INTESTINE
KR102362222B1 (en) * 2016-05-16 2022-02-11 더 제너럴 하스피탈 코포레이션 Human Airway Stem Cells in Lung Epithelial Engineering
CN110225980B (en) 2016-11-21 2023-01-06 纳米线科技公司 Chemical compositions and methods of use thereof
CA3045627C (en) 2016-12-02 2024-10-01 EMULATE, Inc. In vitro gastrointestinal model comprising lamina propria-derived cells
GB2573427B (en) 2016-12-02 2020-12-09 Emulate Inc In vitro epithelial models comprising lamina propria-derived cells
WO2018204913A1 (en) * 2017-05-05 2018-11-08 Tract Pharmaceuticals, Inc. Inflammatory bowel disease stem cells, agents which target ibd stem cells, and uses related thereto
KR102277147B1 (en) * 2017-12-13 2021-07-13 건국대학교 산학협력단 Use of peptides derived from fibroblast growth factor to promote osteogenic or chondrogenic differentiation
EP3732285A1 (en) 2017-12-28 2020-11-04 Tract Pharmaceuticals, Inc. Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
WO2019141824A1 (en) * 2018-01-18 2019-07-25 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Generation, proliferation and expansion of epithelial cells from primary tissue into mucosoid cultures
US20210147811A1 (en) * 2018-04-09 2021-05-20 Cedars-Sinai Medical Center Methods for in vitro expansion of adult tissue stem cells
AU2019250859B2 (en) * 2018-04-13 2025-02-20 Shanghai Lide Biotech Co., Ltd. Method for obtaining an animal model from conditionally reprogrammed cells and use of the animal model for screening anti-tumor drugs
WO2019211734A1 (en) * 2018-04-30 2019-11-07 Avita International Ltd. Immature dental pulp stem cells and methods of use to treat bone marrow failure
EP3814484A4 (en) 2018-05-10 2022-02-23 Agency for Science, Technology and Research CELL CULTURE MEDIUM
EP3794146B1 (en) 2018-05-14 2025-12-10 Bruker Spatial Biology, Inc. Method for identifying a predetermined nucleotide sequence
US12331320B2 (en) 2018-10-10 2025-06-17 The Research Foundation For The State University Of New York Genome edited cancer cell vaccines
CN111254118A (en) * 2018-11-30 2020-06-09 中国科学院大连化学物理研究所 Brain-like tissue generation method of hiPSCs source
WO2020132248A1 (en) * 2018-12-21 2020-06-25 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for airway tissue regeneration
CN109652365A (en) * 2019-02-01 2019-04-19 南京大学 A kind of preparation method of zebrafish embryo single cell suspension
US20210062157A1 (en) * 2019-08-27 2021-03-04 United Therapeutics Corporation Methods and compositions for culturing alveolar cells
US20240158756A1 (en) * 2019-10-10 2024-05-16 University Of Houston System Feeder-based and feeder-free stem cell culture systems for stratified epithelial stem cells, and uses related thereto
CN111471643B (en) * 2020-04-09 2020-12-29 创芯国际生物科技(广州)有限公司 Universal culture medium and culture method for upper respiratory mucosa organoid
US20230203450A1 (en) 2020-05-27 2023-06-29 Otsuka Pharmaceutical Co., Ltd. Method of producing organoid derived from lung epithelial cell or lung cancer cell
CN111560376B (en) * 2020-06-15 2022-03-25 浙江大学 siRNA for specifically inhibiting OLFM4 gene expression and application thereof
CN111808795A (en) * 2020-06-28 2020-10-23 广东省医疗器械研究所 Hepatocyte in-vitro co-culture system and construction method and application thereof
WO2022125438A1 (en) * 2020-12-07 2022-06-16 The Jackson Laboratory Infectious disease mouse models
CN112725259B (en) * 2021-01-07 2023-08-29 福州市皮肤病防治院 Induction medium and induction method for differentiation of stem cells into sweat gland-like cells
KR102574856B1 (en) * 2021-02-05 2023-09-07 연세대학교 산학협력단 Composition for preventing or treating renal disease
CN118787657B (en) * 2024-09-11 2024-12-03 内蒙古大学 Application of nicotinamide adenine dinucleotide in improving cow breeding efficiency
CN120025968A (en) * 2025-01-24 2025-05-23 上海华奥新生命科学有限公司 Method for culturing bronchial epithelial stem/progenitor cells

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464758A (en) 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US6133027A (en) 1996-08-07 2000-10-17 City Of Hope Inducible expression system
US6207455B1 (en) 1997-05-01 2001-03-27 Lung-Ji Chang Lentiviral vectors
WO1998051810A1 (en) 1997-05-13 1998-11-19 University Of North Carolina At Chapel Hill Lentivirus-based gene transfer vectors
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6218181B1 (en) 1998-03-18 2001-04-17 The Salk Institute For Biological Studies Retroviral packaging cell line
DE19909769A1 (en) 1999-03-05 2000-09-07 Bundesrepublik Deutschland Let SIVagm-derived lentiviral vectors, processes for their preparation and their use for gene transfer in mammalian cells
US8075881B2 (en) * 1999-08-05 2011-12-13 Regents Of The University Of Minnesota Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
CA2402459A1 (en) 2000-12-01 2002-06-06 Central Institute For Experimental Animals Method of producing a mouse suitable for engraftment, differentiation and proliferation of heterologous cells, mouse produced by this method and use of the mouse
WO2003030959A1 (en) * 2001-10-06 2003-04-17 Btg International Limited Corneal repair device
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
CN101310012B (en) * 2005-10-14 2012-05-09 明尼苏达大学董事会 Differentiation of non-embryonic stem cells into cells with pancreatic phenotype
EP1999253B1 (en) * 2006-03-02 2019-05-22 Viacyte, Inc. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
ES2453373T3 (en) * 2006-04-14 2014-04-07 Wako Pure Chemical Industries, Ltd. Procedure for introducing a plurality of solutions into a microfluidic channel
AU2008206884B2 (en) * 2007-01-18 2012-07-05 Glykos Finland Oy Novel methods and reagents directed to production of cells
US8383349B2 (en) 2007-03-16 2013-02-26 The Board Of Trustees Of The Leland Stanford Junior University Bone morphogenetic protein antagonist and uses thereof
US10227563B2 (en) * 2008-06-06 2019-03-12 Riken Method for culture of stem cell
EP2297299A1 (en) * 2008-06-25 2011-03-23 INSERM - Institut National de la Santé et de la Recherche Médicale Methods for preparing human skin substitutes from human pluripotent stem cells
EP2412800A1 (en) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
MX379945B (en) * 2009-02-03 2025-03-11 Koninklijke Nederlandse Akademie Van Wetenschappen CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS THAT INCLUDE STEM CELLS.
GB201111244D0 (en) 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
EP2420566A4 (en) * 2009-04-17 2014-01-15 Univ Tohoku METHOD FOR PREPARING HUMAN PULMONARY TISSUE STEM CELLS AND METHOD FOR INDUCING HUMAN ALVEOLAR EPITHELIAL CELL DIFFERENTIATION
US9550975B2 (en) * 2009-07-15 2017-01-24 Mari Dezawa SSEA-3 pluripotent stem cell isolated from body tissue
WO2012044992A2 (en) * 2010-09-30 2012-04-05 Agency For Science, Technology And Research (A*Star) Methods and reagents for detection and treatment of esophageal metaplasia
WO2012168434A1 (en) * 2011-06-08 2012-12-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Partial reprogramming of somatic cells to induced tissue stem (its) cells
WO2014151456A2 (en) * 2013-03-15 2014-09-25 The Jackson Laboratory Treatment of inflammatory diseases
SG11201507510PA (en) * 2013-03-15 2015-10-29 Jackson Lab Isolation of non-embryonic stem cells and uses thereof

Also Published As

Publication number Publication date
EP2970892A1 (en) 2016-01-20
JP2016513469A (en) 2016-05-16
AU2014239954A1 (en) 2015-11-05
AU2014239954B2 (en) 2020-07-16
JP6602745B2 (en) 2019-11-06
TW201522637A (en) 2015-06-16
JP2020018321A (en) 2020-02-06
SG10201708332WA (en) 2017-11-29
US20180179492A1 (en) 2018-06-28
WO2014152321A1 (en) 2014-09-25
US20160060594A1 (en) 2016-03-03
CA2906643A1 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
SG11201507510PA (en) Isolation of non-embryonic stem cells and uses thereof
IL255547A (en) Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
PL2953634T3 (en) Methods for expansion or depletion of t-regulatory cells
EP3060650A4 (en) Culturing pluripotent stem cells
EP2971014A4 (en) Methods of cell culture
EP2971040A4 (en) Methods of cell culture
EP3588586C0 (en) Photovoltaic devices and method of making
SG10202006695TA (en) Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna
IL247798B (en) Expansion of adult stem cells in vitro
IL237244A0 (en) Anti-cd26 antibodies and uses thereof
EP3013944A4 (en) Composition of mesenchymal stem cells
IL244198A0 (en) Transformation of duckweed and uses thereof
EP2949746A4 (en) Method of subculturing pluripotent stem cells
IL274995A (en) Human brown adipose derived stem cells and uses
EP3039162A4 (en) Determination of immune cells and other cells
PL2994150T3 (en) Probiotics and methods of use
IL250495A0 (en) Stem cell compositions and methods of producing stem cells for therapeutic applications
SG11201509437XA (en) Methods and compositions for enhancing stem cell mobilization
IL245272B (en) Pif-transfected cells and methods of use
SG11201507389RA (en) Integration of hydro-dechlorination and hydro-regeneration
EP3008174A4 (en) Method of efficiently establishing induced pluripotent stem cells
GB201315992D0 (en) Fuel cells and method of manufacture
EP2970883B8 (en) Enhanced placental stem cells and uses thereof
SG11201600774TA (en) Method of identifying adipose stem cells
EP2962339A4 (en) Batteries and methods of manufacturing batteries